scholarly article | Q13442814 |
P356 | DOI | 10.1172/JCI109594 |
P953 | full work available at URL | https://europepmc.org/articles/PMC371285 |
https://europepmc.org/articles/PMC371285?pdf=render | ||
P932 | PMC publication ID | 371285 |
P698 | PubMed publication ID | 500818 |
P2093 | author name string | R. E. Canfield | |
K. L. Kaplan | |||
H. L. Nossel | |||
I. Yudelman | |||
J. Wasser | |||
K. S. LaGamma | |||
P2860 | cites work | Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells | Q67264023 |
A radioimmunoassay for platelet factor 4 | Q67436998 | ||
Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates | Q68496780 | ||
Hypertonic saline induced abortion as pathophysiologic model of low grade intravascular coagulation | Q68888797 | ||
Defibrination in saline abortion | Q70506950 | ||
On the primary structure of human fibrinogen. Isolation and characterization of N-terminal fragments from plasmic digests | Q72379528 | ||
A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum | Q72404618 | ||
Human fibrinopeptides isolation, characterization and structure | Q72863514 | ||
A quick and accurate method for the determination of fibronogen in plasma | Q78934157 | ||
A two-step fibrinogen--fibrin transition in blood coagulation | Q34273338 | ||
Measurement of fibrinopeptide A in human blood | Q34463206 | ||
Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes | Q35195488 | ||
The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity | Q35905116 | ||
Radioimmunoassay of Human Fibrinopeptide A | Q37488033 | ||
Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation | Q39496218 | ||
Amino acid sequence studies on plasmin-derived fragments of human fibrinogen. Amino-terminal sequences of intermediate and terminal fragments | Q39731712 | ||
Molecular mechanism of physiological fibrinolysis | Q39861594 | ||
The mechanism of clot dissolution by plasmin | Q40330962 | ||
Unique pattern of fibrinogen cleavage by human leukocyte proteases | Q42149758 | ||
Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis | Q44778969 | ||
Changes in maternal coagulation factors after intra-amniotic injection of hypertonic saline | Q45857259 | ||
High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization | Q47396302 | ||
Defibrination syndrome after intra-amniotic infusion of hypertonic saline | Q53760129 | ||
Platelet Factor 4 and Adenosine Diphosphate Release during Human Platelet Aggregation | Q59095733 | ||
The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis | Q59485564 | ||
The release of a human platelet specific protein measured by a radioimmunoassay | Q66962585 | ||
Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay | Q67253751 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | abortion | Q8452 |
proteolysis | Q33123 | ||
P304 | page(s) | 1371-1378 | |
P577 | publication date | 1979-11-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline | |
Sequence of Fibrinogen Proteolysis and Platelet Release after Intrauterine Infusion of Hypertonic Saline | |||
P478 | volume | 64 |
Q40582622 | Activation markers of coagulation |
Q72778760 | Activation of coagulation and fibrinolytic systems following stroke |
Q40105524 | Chemistry, Measurement, and Clinical Significance of Platelet Specific Proteins |
Q67931088 | Coagulation in aortofemoral bifurcation bypass grafting |
Q40510653 | Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency |
Q41561923 | Exercise-Induced myocardial ischemia in patients with coronary artery disease: Lack of evidence for platelet activation or fibrin formation in peripheral venous blood |
Q69996235 | Fibrinogen--proteolysis in acute myelogenous leukemia (AML) |
Q36999425 | Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation |
Q72789251 | Fibrinopeptide release from fibrinogen |
Q34545184 | Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro |
Q52407987 | Hymie Nossel (11 July 1930 – 8 October 1983) |
Q40683114 | Measurement of desarginine fibrinopeptide B in human blood |
Q48242992 | Metastatic brain tumour and fibrinopeptides |
Q40143046 | Natural anticoagulant mechanisms |
Q38165845 | Plasma levels of platelet secretory proteins |
Q71023663 | Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol |
Q34575165 | Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator |
Q41574733 | Relative proteolysis of the fibrinogen B beta chain by thrombin and plasmin as a determinant of thrombosis |
Q72728831 | Specificity of a monoclonal antibody for the NH2-terminal region of fibrin |
Q33476112 | Studies of β-thromboglobulin, platelet factor 4, and fibrinopeptide a in erythrocytosis due to cyanotic congenital heart disease |
Q70092569 | The effects of a combination of cigarette smoking and oral contraception on coagulation and fibrinolysis in human females |
Q52433576 | The release of Bβ 1–42 from fibrinogen and fibrin by plasmin |
Q72804345 | The significance of fibrinogen derivatives in plasma in human renal failure |
Search more.